Loading organizations...
Shengyu Investment functions as a venture capital and private equity firm based in Shanghai, China, strategically allocating capital to high-potential enterprises. The firm focuses investments across critical sectors including medical health, technology, media, telecommunications, and chemical materials. Its approach centers on identifying and fostering companies poised for substantial growth.
Established in 2009, the firm initiated operations in Shanghai, guided by a clear vision to leverage burgeoning opportunities within China's dynamic economic environment. Its founding premise involved offering essential financial backing and strategic insights to developing and expanding businesses in specialized sectors.
The firm primarily serves a diverse portfolio of companies seeking capital and strategic partnership to scale operations and achieve market leadership. Shengyu Investment's long-term vision aims to cultivate a robust ecosystem of innovative, high-growth companies contributing significantly to advancements in healthcare, technology, and materials, catalyzing sustained value creation.
Shengyu Investment has 2 tracked investments across 2 companies. The latest tracked deal is $4.6M Series A in Golytec Automation in January 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2021 | Golytec Automation | $4.6M Series A | — | — |
| Sep 27, 2020 | Creative Biosciences | $87.9M Series C | — | CDH Investments, IDG Capital, Oceanpine Capital |